CHAMBERS REBECCA (Chief Financial Officer) sold 10.8% of their position (13.28K shares) of VERACYTE, INC. on the open market
Open‑market sale worth $622.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/4/2025ACC: 0001823563-25-000007
Officer· Chief Financial Officer
Since Jul 2021
-16.66K
Net shares
Net seller
$778.2K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
16.66K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−3.38K
Price / share
$46.16
Trade value
$156.21K
% of position
2.7%
12/2/2025
126.16K→122.77K
Common Stock
Direct
Shares
−8.54K
Price / share
$46.61
Trade value
$397.95K
% of position
7.0%
12/4/2025
122.77K→114.24K
Common Stock
Direct
Shares
−4.74K
Price / share
$47.25
Trade value
$224.01K
% of position
4.2%
12/4/2025
114.24K→109.50K
Total
Net shares
−16.66K
Net value
-$778.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/2/2025 | F · Tax Withholding | −3.38K | $46.16 | $156.21K | 2.7% | 126.16K | 122.77K |
| Common Stock Direct | 12/4/2025 | S · Sale | −8.54K | $46.61 | $397.95K | 7.0% | 122.77K | 114.24K |
| Common Stock Direct | 12/4/2025 | S · Sale | −4.74K | $47.25 | $224.01K | 4.2% | 114.24K | 109.50K |
| Total | −16.66K | -$778.16K | ||||||
Derivative Transactions0
No derivative transactions reported